Lv7
4820 积分 2021-11-19 加入
Duration of and time to response in oncology clinical trials from the perspective of the estimand framework
7天前
已完结
Current issues in dose-finding designs: A response to the US Food and Drug Adminstrations’s oncology center of excellence project optimus
12天前
已完结
Bayesian optimal phase II designs with dual‐criterion decision making
13天前
已完结
疼痛评估量表应用的中国专家共识（2020版）
3个月前
已完结
Conditional and Unconditional treatment effects in randomized clinical trials: Estimands, Estimation, and Interpretation
3个月前
已完结
Statistical Issues in Drug Development
5个月前
已完结
Algorithmic benchmark modulation: A novel method to develop success rates for clinical studies
5个月前
已完结
Clinical Trial Design—What is the Critical Question for Decision-Making?
6个月前
已完结
Introduction to Adaptive Trial Designs and Master Protocols
6个月前
已完结
Response to Comment on ”Emerging insights and commentaries – MMRM vs LOCF by Naitee Ting”
6个月前
已完结
皖公网安备34019202002308
